Skip to content
RNAC Cartesian Therapeutics, Inc. Common Stock
$17.48 -9.53% -1.77
Notify me if price changes either direction
Interactive Brokers Logotype

Buy RNAC stocks now with Interactive Brokers – the most advanced investment platform

Contents
  • Performance
  • Key stats
  • Financials
  • US politician trades
Loading

Key Stats

Market cap. 472M
Enterprise value 267.4M
Trailing PE -0.35240962323415
Forward PE -5.3209167
PEG Ratio -5.3209167
Enterprise to EBITDA -6.725
Enterprise to revenue 5.578
Price to book MRQ 599.0323
Price to sales TTM 9.845106

Financials

Fiscal Year Ends 2023-12-31
Most Recent Quarter (MRQ) 2024-09-30
Revenue (TTM) 47.9M
EBITDA -39761000
Diluted EPS TTM -55.43
Total Cash (MRQ) 219.2M
Current ratio (MRQ) 10.705
Operating Cash Flow (TTM) -39958000

RNAC trades by the US politicians

Percentage
0% 0 sells
100% 0 buys
Amount
75% sells
25% buys
Upgrade Today
In the last 0 months

Recent RNAC News

Sign Up

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

Already have an account? Sign In

Services

Disclaimer: The information on this website is for general informational and educational purposes only and does not constitute financial, legal, tax, or investment advice. This site does not make any financial promotions, and all content is strictly informational. By using this site, you agree to our full disclaimer and terms of use. For more information, please read our complete Global Disclaimer.